Id |
Subject |
Object |
Predicate |
Lexical cue |
T393 |
0-70 |
Sentence |
denotes |
SARS‐CoV‐2 shares only 82% of its genome with its relative SARS‐CoV‐1. |
T394 |
71-167 |
Sentence |
denotes |
However, essential viral enzymes of both species show sequence similarities of greater than 90%. |
T395 |
168-287 |
Sentence |
denotes |
137 , 139 , 140 , 141 , 142 SARS‐CoV‐2 3CLpro is highly similar to SARS‐CoV‐1 3CLpro, sharing 96% of its sequence. |
T396 |
288-383 |
Sentence |
denotes |
Therefore, one could expect that SARS‐CoV‐1 Mpro inhibitors are active against SARS‐CoV‐2 Mpro. |
T397 |
384-539 |
Sentence |
denotes |
Compound 40 was found to be active against SARS‐CoV‐2 Mpro and its value of kobs/[I] for the COVID‐19 virus Mpro was determined to be 11 300 ± 880 M−1·s−1. |
T398 |
540-632 |
Sentence |
denotes |
143 Peptide N3 was co‐crystalized with SARS‐CoV‐1 Mpro at 2.1 Å resolution (see Figure 13). |
T399 |
633-723 |
Sentence |
denotes |
Its binding mode to SARS‐CoV‐2 Mpro is highly similar to that of other CoV main proteases. |
T400 |
724-852 |
Sentence |
denotes |
Some key features include the Cys‐His catalytic dyad and the substrate‐binding pocket situated in a gap between domain I and II. |